Boeing (BA)
(Delayed Data from NYSE)
$156.32 USD
+1.74 (1.13%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $156.17 -0.15 (-0.10%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$156.32 USD
+1.74 (1.13%)
Updated Sep 27, 2024 04:00 PM ET
After-Market: $156.17 -0.15 (-0.10%) 7:58 PM ET
4-Sell of 5 4
D Value F Growth F Momentum F VGM
Zacks News
Zacks Earnings Trends Highlights: Ford, Delta Air, Starbucks, Boeing, Alphabet, Coca-Cola and Proctor & Gamble
by Zacks Equity Research
Zacks Earnings Trends Highlights: Ford, Delta Air, Starbucks, Boeing, Alphabet, Coca-Cola and Proctor & Gamble
The Coronavirus Pandemic and its Impact on Corporate Earnings
by Sheraz Mian
For the 193 S&P 500 members that have reported Q1 results, total earnings or aggregate net income is down -17.1% on +0.6% higher revenues...
Boeing (BA) Q1 Earnings Top, Decline Y/Y on Coronavirus Woes
by Aparajita Dutta
Boeing's (BA) Q1 bottom line deteriorates significantly year over year owing to the impacts of the COVID-19 pandemic and 737 Max grounding resulting in lower commercial deliveries.
Gilead's Coronavirus Drug Shows Positive Data
by Zacks Equity Research
Gilead's Coronavirus Drug Shows Positive Data
Positive Data for Gilead's (GILD) Remdesivir; Plus Q1 for BA, GE
by Mark Vickery
This is obviously remarkably good news for COVID-19 suffers, the general public in the throes of this pandemic, and of course Gilead itself.
Boeing (BA) Reports Q1 Loss, Misses Revenue Estimates
by Zacks Equity Research
Boeing (BA) delivered earnings and revenue surprises of 16.67% and -1.60%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?
The Coronavirus Pandemic and its Impact on Corporate Earnings
by Sheraz Mian
For the 193 S&P 500 members that have reported Q1 results, total earnings or aggregate net income is down -17.1% on +0.6% higher revenues...
Coronavirus Crisis Weighs Heavily on U.S. Aerospace Mergers
by Zacks Equity Research
With companies realizing that the desired synergies from mergers will be difficult to achieve, instances of termination of mergers has increased.
Defense Stock Q1 Earnings Reports Due on Apr 29: BA, GD, NOC
by Zacks Equity Research
Q1 earnings of Aerospace sector, comprising defense stocks, is expected to decline 43.5% year over year while revenues are projected to drop 1.1%.
Poor Defense Deliveries to Hit Boeing's (BA) Q1 Earnings
by Zacks Equity Research
Boeing's (BA) Q1 results are expected to reflect poor operational figures on account of dismal deliveries and coronavirus impacts.
A Big Week for Q1 2020 Earnings Session
by Zacks Equity Research
A Big Week for Q1 2020 Earnings Session.
Starting Slow for a Busy Week
by Mark Vickery
We are currently in the heart of earnings season, though the marquee names don't begin reporting until tomorrow.
Poor Commercial Deliveries to Hurt Boeing (BA) Q1 Earnings
by Zacks Equity Research
Boeing's (BA) commercial unit is expected to have incurred higher expenses in the first quarter for storage of undelivered aircraft.
Will Global Services Unit Hurt Boeing's (BA) Q1 Earnings?
by Zacks Equity Research
Boeing's (BA) Q1 results are expected to reflect poor performance of the global services unit, with grounding of 737 Max being the primary growth inhibitor.
Boeing (BA) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Boeing (BA) closed at $134.93, marking a -1.03% move from the previous day.
Analysts Estimate Boeing (BA) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Boeing (BA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
The Market Timing Secrets No One Talks About - April 22, 2020
by Zacks Equity Research
In the long-run, does consistent market timing really matter to be a successful investor?
Hexcel (HXL) Misses on Q1 Earnings, Withdraws 2020 View
by Zacks Equity Research
Hexcel's (HXL) Q1 net sales total $541 million, surpassing the Zacks Consensus Estimate by 3.3%.
Stock Market News for Apr 20, 2020
by Zacks Equity Research
U.S. stocks surged on Friday, thanks to investor optimism over a possible cure to the deadly coronavirus and President Donald Trump's plans to gradually reopen U.S. economy.
Stock Market News for Apr 17, 2020
by Zacks Equity Research
Benchmarks closed in the positive territory on Thursday led by gains in tech-related companies.
Optimism Back in Wall Street? ETFs Areas to Win the Most
by Sanghamitra Saha
Wall Street is likely to stage a relief rally on hopes of reopening of American businesses, improving virus outlook and chances of treatment coming on stream.
Spirit AeroSystems Down on Dismal Q1 Preliminary Results
by Zacks Equity Research
Spirit AeroSystems (SPR) projects revenues of $1,072 million in the first quarter of 2020, which indicates an annual plunge of approximately 46%.
Are Buyback ETFs in Troubled Waters?
by Sanghamitra Saha
With an increasing number of companies suspending buybacks and some cutting the dividend payouts too, the outlook for buyback and dividend ETFs has deteriorated.
Boeing Q1 Commercial Deliveries Down Y/Y on Lower 737 Demand
by Zacks Equity Research
Boeing's (BA) delivery figures show a 66.4% plunge in commercial shipments and a 35% decline in defense shipments year over year.
The Zacks Analyst Blog Highlights: Boeing, General Electric, Raytheon Technologies, Rolls-Royce and Safran
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Boeing, General Electric, Raytheon Technologies, Rolls-Royce and Safran